The cardioprotective role of beta-blockers in patients with diabetes mellitus.
This paper reviews the role of beta-blockers in the prevention of cardiovascular morbidity and mortality in patients with diabetes mellitus. There is good evidence from randomized controlled trials that beta-blockers, in particular the lipophilic agents, substantially reduce cardiovascular mortality...
Hlavní autoři: | Landray, M, Toescu, V, Kendall, M |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2002
|
Podobné jednotky
-
Immunomodulating, metabolic and cardioprotective effects of AT1-angiotensin receptors blocker losartan in patients with coronary heart disease and type 2 diabetes mellitus
Autor: A T Teplyakov, a další
Vydáno: (2009-03-01) -
Cardioprotective role of oleanolic acid in patients with type 2 diabetes mellitus
Autor: Chengrui Li, a další
Vydáno: (2024-06-01) -
Hypoglycemia with Beta-Blocker in Patients with Type II Diabetes
Autor: Rehmat Wali, a další
Vydáno: (2023-07-01) -
THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
Autor: M. A. Maksimova, a další
Vydáno: (2015-09-01) -
THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
Autor: M. A. Maksimova, a další
Vydáno: (2015-09-01)